smooth anesthetic induction with rapid recovery. Although it is a popular intravenous agent, its injection is painful. Population
Exclusion Criterias
120 children ASA 1, 3-15 yrs El.surg.GA
Randomization
GROUP 1 & 2 GROUP 3 & 4
Group 1 : 2 ml Group 3 : 2 ml Saline Saline Group 2 : 1 mg/kg Group 4 : 1 mg/kg Lidocaine Lidocaine
Propofol LCT %1 Propofol Lipuro %1
10 mg/ml 10 mg/ml
Propofol infusion with 600 Propofol infusion with 600
ml/h ml/h
Modified Eastern Ontario Childrens Hospital pain scale was used to
evaluate the injection pain We observed that the best formulation which decreases injection pain was propofol lipuro with lidocaine.
In children, addition of lidocaine to
propofol lipuro solution decreases injection pain to the lowest values. P : Patients with ASA 1, aged 3-15 years I : Propofol without lidocaine C : Propofol with lidocaine O : Decreasing injection pain Are the results of this single preventive or therapeutic Was trialto valid? the assignment of patients Yes treatments randomised? Was the randomisation list concealed?
Was follow-up of patients Yes
sufficiently long and complete? Were the groups similar at the Yes start of the trial?
Were patients and clinicians kept Yes
blind to treatment? Were the groups treated equally, Yes apart from the experimental Were the groups similar at the start of the trial?
Can you apply this valid, important evidence about therapy
in caring for your patient? Do these results apply to your patient? Is your patient so different No from those in the study that its results cannot apply? Is the treatment feasible in Yes your setting? Are your patients values and preferences satisfied by the regimen and its consequences? Do your patient and you have a Yes clear assessment of their values and preferences? Are they met by this regimen Yes and its consequences? CONCLUSION